drugset / Trial / NCT04577612
A Randomized Controlled Test of the Effects of CHI-554 on Fear.
RandomizedParallel-groupDouble-blindPrevention
Summary
This is a randomized, double-blind, placebo-controlled phase 2b clinical trial examining the effects of CHI-554 (CBD) on Fear (F-01)
Timeline
- Start
- 2020-09-01
- Primary completion
- 2021-05-15
- Completion
- 2021-05-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CHI-554 | Unknown | 150 mg | — |
| Subject | CHI-554 | Unknown | 300 mg | — |
| Subject | CHI-554 | Unknown | 600 mg | — |